Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | May 27, 2020 | News story | Research and Development |Â Â COVID-19, coronavirus, coronavirus round upÂ
COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, while a trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK.
In other coronavirus news, People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, while researchers at Harvard have tested macaque monkeys to see if COVID-19 sufferers can contract the virus for a second time.
1. AstraZeneca targets one billion COVID-19 vaccines by September – Published on 21/05/20
AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration with Oxford University.
2. Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS – Published on 20/05/20
People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to new NHS research.
3. Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines – Published 21/05/20
Researchers at Harvard have tested macaque monkeys to see if COVID-19 sufferers can contract the virus for a second time.
4. MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic – Published 20/05/20
A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies for accelerating the regular pace of regulatory approvals in order to create a faster access route to essential treatments and prophylactics during the ongoing COVID-19 pandemic.
5. UK begins hydroxychloroquine trial – Published 21/05/20
A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
